TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $425,000 | -17.6% | 7,765 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $516,000 | -47.3% | 7,765 | -51.4% | 0.00% | -50.0% |
| Q1 2020 | $979,000 | -30.4% | 15,986 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $1,406,000 | -65.1% | 15,986 | -70.1% | 0.01% | -64.3% |
| Q3 2019 | $4,032,000 | -11.7% | 53,441 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $4,564,000 | +26.3% | 53,441 | +59.8% | 0.02% | +23.1% |
| Q1 2019 | $3,614,000 | +23.1% | 33,439 | -3.6% | 0.01% | 0.0% |
| Q4 2018 | $2,937,000 | -17.5% | 34,705 | -4.1% | 0.01% | -7.1% |
| Q3 2018 | $3,558,000 | -7.3% | 36,200 | +9.1% | 0.01% | -17.6% |
| Q2 2018 | $3,838,000 | – | 33,170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |